196 related articles for article (PubMed ID: 17397254)
1. Structural descriptors of gp120 V3 loop for the prediction of HIV-1 coreceptor usage.
Sander O; Sing T; Sommer I; Low AJ; Cheung PK; Harrigan PR; Lengauer T; Domingues FS
PLoS Comput Biol; 2007 Mar; 3(3):e58. PubMed ID: 17397254
[TBL] [Abstract][Full Text] [Related]
2. Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage.
Svicher V; Alteri C; Artese A; Zhang JM; Costa G; Mercurio F; D'Arrigo R; Alcaro S; Palù G; Clementi M; Zazzi M; Andreoni M; Antinori A; Lazzarin A; Ceccherini-Silberstein F; Perno CF;
Antivir Ther; 2011; 16(7):1035-45. PubMed ID: 22024519
[TBL] [Abstract][Full Text] [Related]
3. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.
Verrier F; Borman AM; Brand D; Girard M
AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469
[TBL] [Abstract][Full Text] [Related]
4. Genotypic coreceptor analysis.
Sierra S; Kaiser R; Thielen A; Lengauer T
Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
[TBL] [Abstract][Full Text] [Related]
5. [Biological characteristics of HIV-1 isolates circulating in China are linked to its env V3 loop sequence variability].
Hei FX; Hong KX; Song YH; Tang HL; Peng H; Xu JQ; Xing H; Shao YM
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1968-72. PubMed ID: 15730807
[TBL] [Abstract][Full Text] [Related]
6. Improved prediction of HIV‐1 coreceptor usage with sequence information from the second hypervariable loop of gp120.
Thielen A; Sichtig N; Kaiser R; Lam J; Harrigan PR; Lengauer T
J Infect Dis; 2010 Nov; 202(9):1435-43. PubMed ID: 20874088
[TBL] [Abstract][Full Text] [Related]
7. Small amino acid changes in the V3 loop of human immunodeficiency virus type 2 determines the coreceptor usage for CXCR4 and CCR5.
Isaka Y; Sato A; Miki S; Kawauchi S; Sakaida H; Hori T; Uchiyama T; Adachi A; Hayami M; Fujiwara T; Yoshie O
Virology; 1999 Nov; 264(1):237-43. PubMed ID: 10544150
[TBL] [Abstract][Full Text] [Related]
8. Functional complementation of the envelope hypervariable V3 loop of human immunodeficiency virus type 1 subtype B by the subtype E V3 loop.
Sato H; Kato K; Takebe Y
Virology; 1999 May; 257(2):491-501. PubMed ID: 10329559
[TBL] [Abstract][Full Text] [Related]
9. Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism.
Raymond S; Delobel P; Mavigner M; Cazabat M; Souyris C; Sandres-Sauné K; Cuzin L; Marchou B; Massip P; Izopet J
AIDS; 2008 Sep; 22(14):F11-6. PubMed ID: 18753930
[TBL] [Abstract][Full Text] [Related]
10. Covariance of charged amino acids at positions 322 and 440 of HIV-1 Env contributes to coreceptor specificity of subtype B viruses, and can be used to improve the performance of V3 sequence-based coreceptor usage prediction algorithms.
Cashin K; Sterjovski J; Harvey KL; Ramsland PA; Churchill MJ; Gorry PR
PLoS One; 2014; 9(10):e109771. PubMed ID: 25313689
[TBL] [Abstract][Full Text] [Related]
11. A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support.
Döring M; Borrego P; Büch J; Martins A; Friedrich G; Camacho RJ; Eberle J; Kaiser R; Lengauer T; Taveira N; Pfeifer N
Retrovirology; 2016 Dec; 13(1):85. PubMed ID: 27998283
[TBL] [Abstract][Full Text] [Related]
12. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
[TBL] [Abstract][Full Text] [Related]
13. Analysis of physicochemical and structural properties determining HIV-1 coreceptor usage.
Bozek K; Lengauer T; Sierra S; Kaiser R; Domingues FS
PLoS Comput Biol; 2013; 9(3):e1002977. PubMed ID: 23555214
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for coreceptor selectivity by the HIV type 1 V3 loop.
Cardozo T; Kimura T; Philpott S; Weiser B; Burger H; Zolla-Pazner S
AIDS Res Hum Retroviruses; 2007 Mar; 23(3):415-26. PubMed ID: 17411375
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 coreceptor usage determination in clinical isolates using clonal and population-based genotypic and phenotypic assays.
Van Baelen K; Vandenbroucke I; Rondelez E; Van Eygen V; Vermeiren H; Stuyver LJ
J Virol Methods; 2007 Dec; 146(1-2):61-73. PubMed ID: 17640743
[TBL] [Abstract][Full Text] [Related]
16. Improved prediction of coreceptor usage and phenotype of HIV-1 based on combined features of V3 loop sequence using random forest.
Xu S; Huang X; Xu H; Zhang C
J Microbiol; 2007 Oct; 45(5):441-6. PubMed ID: 17978804
[TBL] [Abstract][Full Text] [Related]
17. Restricted variable residues in the C-terminal segment of HIV-1 V3 loop regulate the molecular anatomy of CCR5 utilization.
Hu Q; Napier KB; Trent JO; Wang Z; Taylor S; Griffin GE; Peiper SC; Shattock RJ
J Mol Biol; 2005 Jul; 350(4):699-712. PubMed ID: 15964018
[TBL] [Abstract][Full Text] [Related]
18. Hybrid approach for predicting coreceptor used by HIV-1 from its V3 loop amino acid sequence.
Kumar R; Raghava GP
PLoS One; 2013; 8(4):e61437. PubMed ID: 23596523
[TBL] [Abstract][Full Text] [Related]
19. Predicting HIV coreceptor usage on the basis of genetic and clinical covariates.
Sing T; Low AJ; Beerenwinkel N; Sander O; Cheung PK; Domingues FS; Büch J; Däumer M; Kaiser R; Lengauer T; Harrigan PR
Antivir Ther; 2007; 12(7):1097-106. PubMed ID: 18018768
[TBL] [Abstract][Full Text] [Related]
20. Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region.
Platt EJ; Kuhmann SE; Rose PP; Kabat D
J Virol; 2001 Dec; 75(24):12266-78. PubMed ID: 11711617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]